StimOxyGen
Coleraine · Founded 2021
About StimOxyGen
StimOxyGen specializes in developing innovative, pH-responsive nanoparticles designed to generate oxygen in hypoxic tumors. This technology aims to enhance the effectiveness of cancer treatments such as radiotherapy and chemotherapy by addressing tumor hypoxia, a significant clinical challenge. F
Company Facts
- Founded: 2021
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $1.9M
- Last round: Series Unknown (Mar 2025)
- Website: https://stimoxygen.com/
- Phone: [email protected]
Industries & Categories
Clinical Trials, Medical, Nanotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/stimoxygen-98435 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.